Genome-wide association studies (GWASs) have identified KLF14 variants to be associated with a multitude of metabolic pathologies, such as insulin resistance (IR), diabetes mellitus, coronary artery disease, ischemic stroke, and myocardial infarction [14,15,16,17]. This evidence concerns the gene KLF14 and diabetes mellitus.